Detalles de la búsqueda
1.
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Blood
; 134(4): 353-362, 2019 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31101627
2.
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Br J Haematol
; 188(5): 685-691, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31612478
3.
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples.
Haematologica
; 104(12): 2456-2464, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30948485
4.
Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.
Int J Cancer
; 143(6): 1335-1347, 2018 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29667176
5.
Exploring the nature of prediagnostic blood transcriptome markers of chronic lymphocytic leukemia by assessing their overlap with the transcriptome at the clinical stage.
BMC Genomics
; 18(1): 239, 2017 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28320322
6.
Prediagnostic plasma concentrations of organochlorines and risk of B-cell non-Hodgkin lymphoma in envirogenomarkers: a nested case-control study.
Environ Health
; 16(1): 9, 2017 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28202064
7.
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.
Blood
; 124(4): 530-5, 2014 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24899624
8.
Prediagnostic telomere length and risk of B-cell lymphoma-Results from the EPIC cohort study.
Int J Cancer
; 135(12): 2910-7, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24771230
9.
Splenic marginal zone lymphoma in Sweden 2000-2020: Increasing rituximab use and better survival in the elderly.
EJHaem
; 4(3): 647-655, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601869
10.
FOXO Dictates Initiation of B Cell Development and Myeloid Restriction in Common Lymphoid Progenitors.
Front Immunol
; 13: 880668, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35603175
11.
High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
Ups J Med Sci
; 1262021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33889307
12.
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years.
EJHaem
; 2(3): 400-412, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35844675
13.
Guided web-based treatment program for reducing cannabis use: a randomized controlled trial.
Addict Sci Clin Pract
; 15(1): 9, 2020 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32070417
14.
Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up.
J Clin Oncol
; : JCO1800262, 2018 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285560
15.
Association between low-grade inflammation and Breast cancer and B-cell Myeloma and Non-Hodgkin Lymphoma: findings from two prospective cohorts.
Sci Rep
; 8(1): 10805, 2018 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30018397
16.
Biomarker Dynamics in B-cell Lymphoma: A Longitudinal Prospective Study of Plasma Samples Up to 25 Years before Diagnosis.
Cancer Res
; 77(6): 1408-1415, 2017 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28108506
17.
Germ line insertions of moloney murine leukemia virus in the TLL mouse causes site-specific differences in lymphoma/leukemia frequency and tumor immunophenotype.
Anticancer Res
; 26(4B): 2873-8, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16886607
18.
Naturally occurring Phe151Leu substitution near a conserved folding module lowers stability of glutathione transferase P1-1.
Biochim Biophys Acta
; 1649(1): 16-23, 2003 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-12818186
19.
Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas.
Leuk Lymphoma
; 56(9): 2598-607, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25686644
20.
Blood erythrocyte concentrations of cadmium and lead and the risk of B-cell non-Hodgkin's lymphoma and multiple myeloma: a nested case-control study.
PLoS One
; 8(11): e81892, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24312375